Back
CG Oncology Inc. CGON · Insights
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cret... Price74.74
Market Cap6.62 B
Float68.28 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro